Stockreport

Leap's lead candidate shows positive action in esophageal cancer study [Seeking Alpha]

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com
PDF Interim results from a Phase 1/2 clinical trial evaluating Leap Therapeutics' ( LPTX ) lead drug DKN-01, combined with Celgene's ( CELG ) Abraxane (paclit [Read more]